相关实验视频

Updated: Jul 3, 2025

Screening for Thermotoga maritima Membrane-Bound Pyrophosphatase Inhibitors

Screening for Thermotoga maritima Membrane-Bound Pyrophosphatase Inhibitors

Published on: November 23, 2019

乙核酸铁酸酶/二酶1抑制剂:研究进展和前景

Dezhong Guan¹, Lincheng Fang², Mingshun Feng³

¹Department of Medicinal Chemistry, China Pharmaceutical University, TongjiaXiang 24, 210009, Nanjing, China.

European journal of medicinal chemistry

|February 15, 2024

概括

乙核核酸酸酶/化酶1 (ENPP1) 是癌症免疫治疗中的一个关键调节剂. 抑制ENPP1有望增强抗瘤效果和对抗癌症的免疫反应.

科学领域:

免疫学免疫学免疫学
在瘤学瘤学.
生物化学生物化学

背景情况:

循环GMP-AMP合成酶 (cGAS) 刺激干扰素基因 (STING) 途径对于先天免疫和癌症免疫疗法至关重要.
乙核核酸酸酶/化酶1 (ENPP1) 通过水解细胞外循环GMP-AMP (cGAMP) 来负面调节cGAS-STING通路.
在包括癌症在内的各种疾病中,ENPP1发挥着重要作用,使其成为潜在的治疗点.

研究的目的:

在癌症免疫治疗的背景下,审查ENPP1的生物功能.
要总结已知的ENPP1抑制剂的结构和结构-活性关系 (SAR).
讨论开发用于癌症治疗的ENPP1抑制剂的未来前景和挑战.

主要方法:

关于ENPP1和癌症免疫治疗的科学出版物的文献综述.
对ENPP1抑制剂的有效性和安全性现有数据的分析.
综合了关于ENPP1在免疫调节和瘤微环境中的作用的信息.

主要成果:

抑制ENPP1通过增加细胞外cGAMP水平来增强STING激动剂的抗瘤功效.
在临床前和临床研究中,ENPP1抑制剂已经显示出显著的抗癌作用,无论是单一治疗还是联合治疗.
了解ENPP1抑制剂的SAR对于设计更强效和选择性的治疗剂至关重要.

结论:

通过调节cGAS-STING通路,ENPP1是增强癌症免疫疗法的有希望的治疗标.
新型ENPP1抑制剂的开发有可能改善各种癌症的治疗结果.
需要进一步的研究来克服挑战,并充分实现ENPP1抑制剂的治疗潜力.

关键词:

2′,3′-cGAMPP的2′,3′-cGAMP的2′,3′-cGAMP的2′,3′-cGAMP的2′,3′-cGAMP的2′,3′-cGAMP的2′,3′-cGAMP的2′,3′-cGAMP的2′,3′-cGAMP的 ENPP1 抑制剂的使用.瘤免疫疗法免疫疗法在cGAS-STING路径中.

更多相关视频

Author Spotlight: Developing Tools to Tune the Activity of Tyrosine Phosphatases

Author Spotlight: Developing Tools to Tune the Activity of Tyrosine Phosphatases

Published on: September 6, 2024

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

相关概念视频

Protein Kinases and Phosphatases

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...

Transducer Mechanism: Enzyme-Linked Receptors

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:

Phosphodiester Linkages

Phosphodiester Linkages

Overview
Phosphodiester bond forms when a phosphoric acid molecule (H3PO4) links with two hydroxyl groups (–OH) of two other molecules, forming two ester bonds. Two water molecules are released in this process. The phosphodiester bond is commonly found in nucleic acids (DNA and RNA) and plays a critical role in their structure and function.
Phosphodiester Bonds Link Nucleotides Together
DNA and RNA are polynucleotides or long chains of nucleotides that are linked together. A nucleotide is...

Phosphoinositides and PIPs

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...